Daily equity-report by epic research 1 february 2013
HEADLINES -=6 Indian Market Indian equity markets were down -0.35% Nifty down by 21.00 pts and settle at 6034.75 Sensex down by 110.02 pts at 19894.98 Bank Nifty down by 74.25 pts at 12707.90 DAILY EQUITY Global Market NEWSLETTER European markets were down with FTSE ST down by 27.26 closed at 6295 ,CAC down 1 FEBUARY 2013 by 22.77 closed at 3742 and DAX down by 22.85 closed at 7788. Dow future was up 2.00 closed at 13840.00 HEADLINES• ICICI Bank Q3 profit rises 30% on higher NII & other income• Hope to maintain NIM guidance of 3.52 % for FY13: PNB• Allahabad Bank Q3 profit falls 45% to Rs 311cr, shares down• PFC rises nearly 3% on UBS buy report post Q3 earnings WWW.EPICRESEARCH.CO 09752199966
MARKET ANALYSIS: Key benchmark indices edged lower in choppy trade after data released by the US Commerce Department on Wednesday, 30 January 2013, showed a surprise fourth-quarter contraction in the US economy which is the worlds biggest economy. The barometer index, BSE Sensex, hit two-week low. BSE Sensex was down 106.06 points or 0.53% to 19,898.94. S&P CNX Nifty was down 22.15 points or 0.37% to 6,033.60. Among the 30-share Sensex pack, 21 stocks fell while the rest of them rose. Index heavyweight and cigarette maker ITC rose 1.45% to Rs 308. The stock hit record high of Rs 308.75 in late trade today, 31 January 2013. Jet Airways (India) jumped 4.96% to Rs 625.80 after the Ministry of Commerce & Industry today, 31 January 2013, said that a delegation of Jet Airways and Etihad Airlines of UAE including Mr. Naresh Goyal, Chairman Jet Airways and James Hogan, President and CEO of Etihad Airways met Union Minister of Commerce Industry and Textiles Mr. Anand Sharma. Power Finance Corporation (PFC) gained 1.33%. PFC after market hours on Wednesday, 30 January 2013, reported 1% growth in net profit to Rs 1117 crore on 36% growth in total income to Rs 4466 crore in Q3 December 2012 over Q3 December 2011. Punjab National Bank (PNB) jumped 9.92% on good Q3 results. The banks net profit rose 13.52% Rs 1305.62 crore on 10.38% increase in total income Rs 11518.95 crore in Q3 December 2012 over Q3 December 2011. STOCKS TO WATCH FII’s and DII’s ALLAHBAD BANKCATEGORY DATE BUY SELL NET HDFC FII 31-Jan-13 5426.07 4467.14 958.93 PFC BHEL DII 31-Jan-13 1456.11 2319.71 -863.6 SCRIPS IN BAN PERIOD NIFTY DAILY PIVOTS WELCORPPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 6138 6105 6072 6053 6039 6020 6006 5973 5940 WWW.EPICRESEARCH.CO 09752199966
. GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS Nifty looks ConsolidateSCRIPS RATE VOL. PR. NET % Strategy: Sell on rise (000) CLOSE CHAN CHANG GE E Support: 5990 PNB 912.10 7464.41 833.65 78.45 9.41 Resistance: 6070 BANK NIFTYBank Of 867.75 1414.80 832.30 35.45 4.26Baroda Bank Nifty looks Consolidate BHEL 227.80 5306.83 221.75 6.05 2.73 Strategy: Sell on rise Support: 12630 DLF 277.60 17413.60 271.65 5.95 2.19 Resistance: 12770 Ambuja 203.90 3606.91 200.25 3.65 1.82 .0Cement PREVIOUS PERFORMANCE TYPE SCRIP B/S RESULT DAILY NIFTY LOOSERSSCRIPS RATE VOL. PR. NET % CASH ONGC B SL TRIGERRED (000) CLOSE CHAN CHAN CASH HDIL S SL TRIGERRED GE GE Tata FUTURE INDUSIND B TARGET HIT 101.10 3987.66 103.40 -2.30 -2.22 Power HDFC BHARTI 643.05 3472.10 656.65 -13.60 -2.07 FUTURE S TARGET HIT Bank AIRTEL ICICI 1191.15 7006.29 1212.70 -21.55 -1.78 Bank Ranbaxy 447.65 825.74 455.30 -7.65 -1.68 Labs. UPCOMING RESULTS Bharti Airtel 339.60 4275.19 344.60 -5.00 -1.45 IDFC TVS JET AIRWAYS BHEL ADANI MCX WWW.EPICRESEARCH.CO 09752199966
MARKET CALLS CASH SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS BHEL BUY 230.00 232.00 235.00 228.00 ALLAHABAD BANK SELL 162.30 161.30 159.80 163.30 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. HDFC SELL 784.40 780.40 776.40 788.40 PFC BUY 212.50 213.50 215.00 211.50 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.